Citadel Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-999
| Closed | -$37.8K | – | 6662 |
|
|
2023
Q1 | $37.8K | Buy |
999
+919
| +1,149% | +$34.7K | ﹤0.01% | 5247 |
|
|
2022
Q4 | $2.37K | Sell |
80
-961
| -92% | -$28.5K | ﹤0.01% | 5870 |
|
|
2022
Q3 | $35K | Buy |
+1,041
| New | +$35K | ﹤0.01% | 5416 |
|
|
2022
Q2 | – | Sell |
-2,487
| Closed | -$131K | – | 7138 |
|
|
2022
Q1 | $131K | Buy |
2,487
+1,398
| +128% | +$73.6K | ﹤0.01% | 5519 |
|
|
2021
Q4 | $60K | Sell |
1,089
-734
| -40% | -$40.4K | ﹤0.01% | 6105 |
|
|
2021
Q3 | $141K | Buy |
1,823
+1,160
| +175% | +$89.7K | ﹤0.01% | 5637 |
|
|
2021
Q2 | $86K | Sell |
663
-59
| -8% | -$7.65K | ﹤0.01% | 6029 |
|
|
2021
Q1 | $119K | Buy |
722
+106
| +17% | +$17.5K | ﹤0.01% | 5749 |
|
|
2020
Q4 | $144K | Buy |
+616
| New | +$144K | ﹤0.01% | 4594 |
|
|
2020
Q3 | – | Sell |
-1,238
| Closed | -$49K | – | 5414 |
|
|
2020
Q2 | $49K | Buy |
+1,238
| New | +$49K | ﹤0.01% | 4384 |
|
|
2020
Q1 | – | Sell |
-802
| Closed | -$38K | – | 5433 |
|
|
2019
Q4 | $38K | Buy |
802
+636
| +383% | +$30.1K | ﹤0.01% | 4427 |
|
|
2019
Q3 | $15K | Buy |
166
+103
| +163% | +$9.31K | ﹤0.01% | 4555 |
|
|
2019
Q2 | $9K | Buy |
+63
| New | +$9K | ﹤0.01% | 4572 |
|
|
2019
Q1 | – | Sell |
-132
| Closed | -$17K | – | 5143 |
|
|
2018
Q4 | $17K | Buy |
132
+29
| +28% | +$3.74K | ﹤0.01% | 4320 |
|
|
2018
Q3 | $42K | Buy |
+103
| New | +$42K | ﹤0.01% | 4022 |
|
|
2018
Q1 | – | Sell |
-99
| Closed | -$66K | – | 4507 |
|
|
2017
Q4 | $66K | Buy |
+99
| New | +$66K | ﹤0.01% | 3577 |
|